This record was last updated November 22, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
Betalains have well-known antioxidant and anti-inflammatory properties. Recent investigations examining the effects of a betalain-rich concentrate (BRC) on exercise and recovery performance show promise of BRC as an ergogenic aid. To date, no study has examined the effects of a single dose of a BRC on supramaximal performance and recovery. Therefore, the purpose of this study is to examine the effects of an acute dose of BRC on repeated-sprint cycling performance and recovery.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-15; most recent amendment 2024-11-20.